Andembry 200 mg
As listed in the register: Andembry 200 mg, Injektionslösung im Fertigpen
200 mg ·
- Prescription only
- Blood, clotting and anaemia
- Active substance
- Garadacimabum
- Used in
- Blood, clotting and anaemia
- Made by
- CSL Behring AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Langzeitprophylaxe wiederkehrender akuter Schübe des hereditären Angioödems (HAE) bei erwachsenen und pädiatrischen Patienten ab 12 Jahren.
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | CSL Behring AG |
|---|---|
| Active substance | Garadacimabum |
| Used in | Blood, clotting and anaemia |
| Strength | 200 mg |
| Classification | B06AC07 · Blood, clotting and anaemia |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Andembry 200 mg, Injektionslösung im Fertigpen |
| Packs | 1 Fertigpen |
| Zulassungsnummer | 69553 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.